TOM70 Antibody (Rabbit mAb) [N12A7]

CatNo: F7444

    Application: Reactivity:
    • Lane 1: HepG2, Lane 2: Hela, Lane 3: Mouse brain, Lane 4: Rat brain
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:30
    1:2000
    1:100
    1:500
    Application
    WB, IP, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    67 kDa 72 kDa, 70 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human cerebrum tissue; Human colon tissue; Human breast cancer tissue; Human esophagus tissue; Mouse brain tissue; Mouse liver tissue; Rat brain tissue; Rat liver tissue; Rat breast tissue; HeLa cells; U-2 OS cells; HepG2 cells; NIH/3T3 cells; C6 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    TOM70 Antibody (Rabbit mAb) [N12A7] detects endogenous levels of total TOM70 protein.
    タンパク質の局在
    細胞内膜系、ミトコンドリア、ミトコンドリア外膜
    Uniprot ID
    O94826
    Clone
    N12A7
    Synonym(s)
    KIAA0719, TOM70, TOMM70A, TOMM70, Translocase of outer mitochondrial membrane protein 70
    Background
    TOM70 (TOMM70) is a tetratricopeptide repeat (TPR)–containing receptor of the translocase of the outer mitochondrial membrane (TOM) complex that links cytosolic chaperone–bound preproteins to the general import pore and, in mammalian cells, also serves as an adaptor that couples mitochondrial antiviral signaling to IRF3‑dependent transcription and virus‑induced apoptosis. The cytosolic domain is entirely helical and organized into repeated TPR motifs that form two functionally specialized regions: an N‑terminal clamp that recognizes conserved C‑terminal EEVD motifs in Hsp70/Hsc70 and Hsp90, and a C‑terminal preprotein‑binding groove that engages internal targeting signals and internal MTS‑like segments within carrier‑type and other nonclassical mitochondrial precursors, while a single C‑terminal transmembrane anchor tethers TOM70 to the outer membrane facing the cytosol. In mitochondrial protein biogenesis, TOM70 recognizes hydrophobic or complex preproteins presented as Hsp70/Hsp90–substrate complexes, binds both chaperone and client simultaneously, and positions the preprotein for transfer into the TOM40 channel, enhancing import efficiency especially for carriers and other presequence‑containing substrates that harbor distributed internal targeting information; loss or mutation of TOM70 reduces import of a broad set of hydrophobic and multi‑pass proteins, increasing the burden of mistargeted precursors in the cytosol and triggering mitoprotein stress. Structural and biochemical work indicates that conformational changes between open and closed states of the TPR array, transmitted via specific helices, coordinate chaperone engagement and preprotein handover, and that Tom70‑dependent recruitment of chaperones to the mitochondrial surface is a major determinant of its protective role against proteotoxicity from accumulating mitochondrial precursors. In innate immunity, TOM70 functions as a mitochondrial adaptor for RIG‑I–like receptor signaling: MAVS residing on the outer membrane recruits TOM70, which then binds Hsp90‑associated TBK1 and IRF3 to form a signaling platform that facilitates IRF3 phosphorylation and type I interferon production after infection with RNA viruses such as Sendai virus, integrating mitochondrial interface dynamics with antiviral transcriptional responses. Under the same stimulus, TOM70 also assembles a pro‑apoptotic complex containing HSP90AA1, IRF3, and the proapoptotic BCL‑2 family member BAX on the mitochondrial surface; IRF3 in this complex adopts a non‑transcriptional effector role that cooperates with BAX to permeabilize mitochondria and promote apoptosis, coupling antiviral signaling to elimination of infected cells through a TOM70‑dependent mechanism. Across these pathways, TOM70 occupies a dual position as a core receptor in mitochondrial import and as a scaffold at the mitochondrial outer membrane that recruits chaperones, kinases, transcription factors, and apoptosis regulators.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください